Indeed, miR-106b-25 cluster is shown to regulate the TGF-β pathway by targeting Six1 and Smad7, which are required to activate TGF-β pathway from suppressive to supportive tumor growth in human breast cancer [97–99]. Here, TGFB1 is linked to neoplasm.